7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver (original) (raw)

Archives of Biochemistry and Biophysics, 1997

Associate editor: H. Bönisch Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

天鹏张

View PDFchevron_right

Inhibition and induction of human cytochrome P450 enzymes: current status

Paavo Honkakoski

Archives of Toxicology, 2008

View PDFchevron_right

Cytochromes P450 and experimental models of drug metabolism

Eva Anzenbacherova

Journal of Cellular and Molecular Medicine, 2002

View PDFchevron_right

The pharmacology of the cytochrome P450 enzyme system

Munir Pirmohamed

1998

View PDFchevron_right

Cytochrome P450 2C24: expression, tissue distribution, high-throughput assay, and pharmacological inhibition

James Phillips

Acta Pharmaceutica Sinica B, 2012

View PDFchevron_right

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

Wichittra Tassaneeyakul

British Journal of Clinical Pharmacology, 1993

View PDFchevron_right

Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition

Walter Westerink

Archives of Toxicology, 2008

View PDFchevron_right

Cytochrome P450 (CYP) inhibition screening: Comparison of three tests

Jouko Uusitalo

European Journal of Pharmaceutical Sciences, 2006

View PDFchevron_right

Cytochrome P450 – Role In Drug Metabolism And Genetic Polymorphism

Anitha Rajan

2018

View PDFchevron_right

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5

John Schuetz

Pharmacological reviews, 2004

View PDFchevron_right

CYTOCHROME P450-MEDIATED TOXICITY OF THERAPEUTIC DRUGS

Mariana Matias

View PDFchevron_right

Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR

Etienne Caron

Journal of Biochemical and Molecular Toxicology, 2006

View PDFchevron_right

Cytochrome P450 Part 3: Impact of Drug-Drug Interactions

Ross McKinnon

Journal of Pharmacy Practice and Research, 2009

View PDFchevron_right

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

Sebastian Raimundo

Naunyn-Schmiedeberg's Archives of Pharmacology, 2004

View PDFchevron_right

Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5

Rheem Totah

Biochemical Pharmacology, 2011

View PDFchevron_right

Drug-metabolizing cytochrome P450s in the brain

Rachel Tyndale

Journal of Psychiatry Neuroscience Jpn, 2002

View PDFchevron_right

Stable Expression of Human Cytochrome P450 3A4 in Conjunction with Human NADPH-Cytochrome P450 Oxidoreductase in V79 Chinese Hamster Cells

els groene

Archives of Biochemistry and Biophysics, 1996

View PDFchevron_right

Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(−/−) mice

Laura Hathaway

Chemico-Biological Interactions, 2009

View PDFchevron_right

Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes

Gregory Wagner

Drug Metabolism and Disposition, 2003

View PDFchevron_right

Cytochrome P450 Part 1: Multiplicity and Function

Ross McKinnon

Journal of Pharmacy Practice and Research, 2008

View PDFchevron_right

Regulation of drug-metabolizing human cytochrome P450s

Katalin Monostory

Acta Chimica Slovenica, 2008

View PDFchevron_right

Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions

Kellie Reynolds

Drug Metabolism and Disposition, 2002

View PDFchevron_right

Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro

Benjamin Lewis

Journal of Pharmacology and …, 2004

View PDFchevron_right

Chromatographic assays of drug oxidation by human cytochrome P450 3A4

Christal Sohl

Nature Protocols, 2009

View PDFchevron_right

Tumour Cytochrome P450 and Drug Activation

laurence patterson

Current Pharmaceutical Design, 2002

View PDFchevron_right

2 CYP450 Enzymes in Drug Discovery and Development: An Overview

Biplab Das

View PDFchevron_right

Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans

Hiroshi Yamazaki

Archives of Toxicology, 1997

View PDFchevron_right

Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4'Methyl -pyrrolidinobutyrophenone

Hilde Bohets

Drug Metabolism and Disposition, 2007

View PDFchevron_right

Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation

Stacy Shord

Drug Metabolism and Disposition, 2001

View PDFchevron_right

Effect of diphenoxylate on CYP450 isoforms activity in rats

zezheng liu

International journal of clinical and experimental medicine, 2015

View PDFchevron_right

Cytochrome P 450 enzymes induced roles in pharamacokinetic and drug interaction

Pálma Porrogi

2016

View PDFchevron_right

Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism

Tin-tin Lu

European Journal of Pharmacology, 2000

View PDFchevron_right

7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver (original) (raw)

Related papers